Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics

about

Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics

Item

http://www.wikidata.org/entity/Q58796089

description

scientific article published on 08 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Efficient formation of inert B ...... ds improved alpha-therapeutics

@en

Efficient formation of inert B ...... ds improved alpha-therapeutics

@nl

type

Item

label

Efficient formation of inert B ...... ds improved alpha-therapeutics

@en

Efficient formation of inert B ...... ds improved alpha-therapeutics

@nl

prefLabel

Efficient formation of inert B ...... ds improved alpha-therapeutics

@en

Efficient formation of inert B ...... ds improved alpha-therapeutics

@nl

P1476

Efficient formation of inert B ...... ds improved alpha-therapeutics

@en

P2093

Alfred Morgenstern

http://www.w3.org/2001/XMLSchema#string

Christof Seidl

http://www.w3.org/2001/XMLSchema#string

Frank Bruchertseifer

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Jakub Šimeček

http://www.w3.org/2001/XMLSchema#string

Petr Hermann

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha emitter radium-223 and survival in metastatic prostate cancer

Tumor therapy with targeted atomic nanogenerators.

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.

Radioimmunotherapy with α-particle-emitting radionuclides.

A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters?

²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

Relaxometry, animal biodistribution, and magnetic resonance imaging studies of some new gadolinium (III) macrocyclic phosphinate and phosphonate monoester complexes.

Targeted alpha therapy with 213Bi.

The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.

Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.

P2888

s13550-018-0431-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13550-018-0431-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Notni

P577

2018-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106057873

http://www.w3.org/2001/XMLSchema#string

P698

30091088

http://www.w3.org/2001/XMLSchema#string

P932

6082748

http://www.w3.org/2001/XMLSchema#string